Which has stronger earnings & valuation, ALVOW or AIMDW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $586.32M N/A N/A N/A N/A Ainos $18.11K N/A N/A N/A N/A

Is ALVOW or AIMDW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Ainos N/A N/A N/A

Which has preferable earnings & valuation, ALVOW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $586.32M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is ALVOW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Aravive N/A N/A N/A

Which has higher earnings and valuation, ALVOW or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $586.32M N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is ALVOW or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Which has preferable earnings & valuation, ALVOW or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $586.32M N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is ALVOW or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Biofrontera N/A N/A N/A

Which has higher valuation & earnings, CELUW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Alvotech $586.32M N/A N/A N/A N/A

Is CELUW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Alvotech N/A N/A N/A

Alvotech (ALVOW) Competitors

$0.23 +0.06 (+39.00%)

As of 03:51 PM Eastern

Compare

ALVOW vs. AIMDW, ARAV, ACABW, BFRIW, and CELUW

Should you buy Alvotech stock or one of its competitors? MarketBeat compares Alvotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alvotech include Ainos (AIMDW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Alvotech compare to Ainos?

Alvotech (NASDAQ:ALVOW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

In the previous week, Ainos had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.44 beat Ainos' score of 0.62 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Ainos	Positive

Summary

Alvotech beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Alvotech (NASDAQ:ALVOW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Aravive	Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Alvotech compare to Atlantic Coastal Acquisition Corp. II?

Alvotech (NASDAQ:ALVOW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

In the previous week, Alvotech had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Atlantic Coastal Acquisition Corp. II. Alvotech's average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Atlantic Coastal Acquisition Corp. II	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

Summary

Alvotech beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Biofrontera?

Alvotech (NASDAQ:ALVOW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

In the previous week, Alvotech and Alvotech both had 1 articles in the media. Alvotech's average media sentiment score of 1.44 beat Biofrontera's score of 0.43 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Positive
Biofrontera	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

Summary

Alvotech beats Biofrontera on 2 of the 2 factors compared between the two stocks.

How does Alvotech compare to Celularity?

Celularity (NASDAQ:CELUW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

In the previous week, Celularity had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Celularity and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.44 beat Celularity's score of 0.76 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Celularity	Positive
Alvotech	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Alvotech beats Celularity on 2 of the 3 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALVOW vs. The Competition

Export

Metric	Alvotech	Drug Manufacturers Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$2.43B	$6.25B	$12.42B
Dividend Yield	N/A	2.94%	2.69%	5.29%
P/E Ratio	N/A	5.21	22.30	24.19
Price / Sales	N/A	1,776.16	581.37	138.33
Price / Cash	N/A	10.18	42.31	57.88
Price / Book	N/A	10.85	9.84	6.72
Net Income	N/A	$20.70B	$3.57B	$337.19M
7 Day Performance	-14.85%	-0.07%	-1.16%	0.48%
1 Month Performance	8.14%	4.30%	3.85%	5.06%
1 Year Performance	-90.46%	15.65%	27.40%	34.27%

Alvotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALVOW Alvotech	N/A	$0.23 +39.0%	N/A	-93.4%	$0.00	$586.32M	N/A	4	Short Interest Decrease Gap Down
AIMDW Ainos	N/A	$0.06 -13.3%	N/A	-15.3%	$0.00	$18.11K	N/A	40	Gap Down
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	-86.1%	$0.00	N/A	N/A	15
BFRIW Biofrontera	N/A	$0.02 -27.3%	N/A	-67.0%	$0.00	$43.20M	N/A	70	Short Interest Increase Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALVOW) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alvotech (ALVOW) Competitors